Feline Medicine

Updates on Feline CKD Management 

What’s new in feline CKD?? This session will highlight updates on medical management including approach to dietary therapy in early and late stage CKD. Special emphasis will be given to factors that may be important for quality of life such as anemia, appetite and hydration.  The attendee will:

• Appreciate the differences in the formulations of renal diets and consider the selection of appropriate choices for individual patients
• Consider quality of life in the feline patient and prioritize medical therapies
• Understand why anemia is a concerning sequelae of CKD and how it can be addressed
• Be aware of altered pharmacokinetics of gabapentin in CKD that necessitate dose reduction as well as its effect on blood pressure

Dr. Quimby received her veterinary degree from the University of Wisconsin-Madison and
completed a small animal rotating internship in Sacramento, CA. She subsequently spent two
years in feline practice in Grand Rapids, Michigan before moving on to Colorado State University for a combined small animal internal medicine residency and PhD program. She completed a PhD focusing on feline CKD in 2012 and was faculty at Colorado State until 2017. Dr. Quimby is now a faculty member at the Ohio State University. Her research continues to focus on chronic kidney disease in cats. Current research areas include the study of renal aging, telomere length and cellular senescence, novel treatment strategies, and evidence-based supportive care strategies. She has an interest in clinical trials and feline clinical pharmacology, which is aimed at improving supportive care and quality of life in cats with chronic kidney disease. Dr. Quimby has received the International Renal Interest Society (IRIS) Award and the AVMF/Winn Feline Foundation Research Award for her contributions to nephrology and feline medicine. In 2021, she was selected to serve on the IRIS board.